Some antidepressants can influence blood sugar levels, which is relevant for patients with diabetes who are taking medications like Ozempic
Longer term For longer repeated exposure, review broad health, inflammation, and copper-context markers every 3-6 months with a clinician
FDA-approved GLP-1 receptor agonists, such as Ozempic, Wegovy, and older drugs like liraglutide (Saxenda, Victoza) and dulaglutide (Trulicity), have revolutionized treatment by enabling: Better blood sugar control in type 2 diabetes patients Weight loss support through appetite regulation and delayed digestion Potential reduction in cardiovascular risk for some patients While these drugs have become increasingly popular for metabolic health care, they can come with side effects like gastrointestinal discomfort, and must be taken under medical supervision
Unlike Melanotan II, KPV does not activate melanocortin receptors